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ABSTRACT
Coronary chronic total occlusions (CTOs) are a commonly encountered lesion. These present 
in a diverse patient population with variable anatomy. Technical success rates of ~90% are 
achievable for CTO lesions in centers with appropriate expertise. Many lesions can be crossed 
with wire-based techniques. However, the most anatomically complex and technically 
challenging lesions will often require more advanced approaches such as retrograde access 
and/or the application of blunt dissection techniques in the vessel to safely navigate long 
and/or ambiguous CTO segments. Retrograde dissection and re-entry (RDR) and antegrade 
dissection and re-entry (ADR) strategies are often needed to treat such lesions. In many 
circumstances, ADR offers a safe and efficient means to successfully cross a CTO lesion. 
Therefore, operators must remain cognizant of the risks and benefits of differing technical 
approaches during CTO percutaneous coronary intervention, particularly when both ADR 
and RDR are feasible. This article provides an overview of the ADR technique in addition to 
updated approaches in contemporary clinical practice.
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INTRODUCTION
Antegrade dissection and re-entry (ADR) refers to an attempt to cross a coronary chronic 
total occlusion (CTO) lesion that leads to wire and/or equipment passage in the sub-intimal 
space (SIS) followed by re-entry to the distal true lumen. The re-entry point can occur at 
different sites and is dependant on the specific ADR technique that is employed. In reality, 
many wire-based CTO percutaneous coronary intervention (PCI) approaches lead to sub-
intimal wire passage, particularly as the lesions become longer and more complex.1-3) Whilst 
blunt dissection is not employed as part of this wire based recanalization, the end result is 
of a deployed stent that passes from the proximal true lumen, via a segment in the SIS to 
the distal true lumen. This is often an unrecognized occurrence, especially if intravascular 
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ultrasound (IVUS) or optical coherence tomography is not performed prior to stent 
deployment, but is not known to be associated with adverse outcomes.
ADR as a dedicated technique was initially adapted from peripheral intervention and was first 
described in the coronaries as the sub-intimal tracking and re-entry (STAR) technique.4) This 
involved pushing a looped or ‘knuckled’ guidewire (usually polymer jacketed) from within 
the CTO body until it re-entered the distal true lumen. The technique was adapted to involve 
the use of intra-lesion contrast injection5) as well as for bail-out when some of the CTO lesion 
was wired as an initial strategy (mini-STAR).6) However, this approach was associated with 
uncontrolled re-entry that was typically distal, often at a bifurcation and that could lead to 
run-off into 1 terminal branch. Unsurprisingly, the long-term results were poor with high 
rates of repeat revascularization and target vessel occlusion.7-9) Today, STAR or mini-STAR do 
still represent a small proportion of successful ADR cases, being accepted as an inadvertently 
successful technique when knuckle wires re-enter the vessel at or close to the distal cap.
Further adaptations of practice occurred over time as it was realized that STAR and its 
variations were sub-optimal approaches. One early evolution without dedicated equipment 
was limited antegrade sub-intimal tracking (LAST). This approach involved an initial 
wire-based approach to cross the CTO lesion. Once it was recognized that the wire was in 
a sub-intimal position, the guidewire was swapped out via a micro-catheter and a tapered 
tip, high penetration force guidewire was shaped with significantly angled primary and 
secondary bends in an effort to puncture back into the true lumen. However, re-entry was 
relatively unreliable, also unpredictable in terms of its location relative to the distal cap and 
this technique was also associated with less favorable outcomes.10) LAST as a concept may 
still be applied in some geographies where dedicated ADR devices are either unavailable or 
prohibitively expensive. The use of standard dual lumen catheters is also sometimes applied 
to try to assist re-entry. However, the overall reliability of this technique and systematic 
examination of outcomes are poorly understood.
The CrossBoss and Stingray system (Figure 1; Boston Scientific, Marlborough, MA, USA) 
have been developed as a combination of devices that can create a controlled antegrade 
dissection plane to facilitate targeted distal vessel re-entry.11) The CrossBoss catheter is a 
blunt dissection tool with a 1 mm rounded tip that will either track through intimal plaque 
and re-enter the distal true lumen itself (<10% of cases) or alternatively create a controlled 
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CrossBossTM Stingray & Stingray WireTM
Figure 1. The CrossBoss and Stingray catheters.
dissection plane in the SIS that allows the Stingray balloon to be delivered just beyond the 
distal cap of the occlusion. This allows a focused puncture back into the vital vessel at a 
precisely controlled site and thus revascularization of all the distal branches. Application of 
this technique promotes reproducibility as well as predictability of the re-entry site. In many 
geographies this has become the dominant mode of ADR in contemporary practice.
Newer technologies are in development with adaptations of re-entry devices from dual lumen 
catheters. One such device in early clinical development is the Recross (IMDS, Drenthe, 
Netherlands), although others are also approaching clinical use. Where these devices will fit 
in future clinical practice of ADR remains to be seen.
A FOCUS ON UPDATED TECHNICAL APPROACHES USING 
THE CROSSBOSS/STINGRAY SYSTEM
Algorithmic approaches to CTO lesions have been recommended for several years.12)13) Whilst 
many lesions are amenable to multiple strategies, the most complex CTOs will often require an 
ADR or retrograde dissection and re-entry (RDR) based approach. Nevertheless, the majority 
of lesions that are attempted in global practice usually begin with an antegrade wire (AW) 
approach. It is not uncommon, especially in increasingly long lesions for the wire to pass 
beyond the distal cap of the CTO in the SIS. On occasion this can be resolved by redirection of 
the wire within the CTO body. Some would also advocate parallel wiring to try to resolve this 
issue. Nevertheless, it is not uncommon for the distal true lumen to be inaccessible. Under 
these circumstances, we would advocate consideration of an early switch to a controlled 
ADR technique, provided that there is no major distal side-branch at the landing zone. One 
evolution from historical practice when ADR is performed as a bail out for unsuccessful AW is 
that blunt dissection with knuckle wires or a CrossBoss device is often unnecessary.
Consider the example shown in Figure 2. There is a moderate length lesion in a dominant 
right coronary artery. AW approaches are unsuccessful with both a low penetration force 
polymer jacketed wire (Fighter; Boston Scientific) and medium gram force wire (Pilot 200; 
Abbott Vascular, Santa Clara, USA). Once the Pilot 200 has progressed beyond the distal 
cap into the SIS, there is an immediate switch to an ADR approach. A CrossBoss device is 
not required. Rather, the coil-based micro catheter that is already in situ in the CTO is used 
to create a space to facilitate Stingray delivery. This minimizes the time and maneuvers that 
are required to progress the case to the point of puncture and re-entry. The end result is 
minimal hematoma formation, preservation of the landing zone and successful re-entry in 
a time efficient manner. All distal branches are preserved and costs have been reduced as a 
CrossBoss device was not required.
Primary ADR is classically applied in the setting of defined proximal cap anatomy (by 
angiography or IVUS), where the CTO segment is long (and/or ambiguous) and when there is 
a landing zone that is proximal to a distal bifurcation at significant branches (Figure 3). Once 
again, practice has evolved over time. The miniaturization of equipment and in particular 
the advent of the Stingray LP and dedicated trapping balloons have obviated the need for 
the use of 8F guiding catheters. In our practice, where Caucasian patients often have larger 
caliber radial arteries, 7F access has become preferred for CTO PCI. This usually leads to a 
transradial approach. However, this may not be feasible in all geographies or patient groups. 
A standard step-by-step approach to a more complex lesion with primary ADR is outlined 
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in Figures 3-5. Typically, the proximal cap is crossed. A balloon is used to introduce a guide 
catheter extension (most often Trapliner; Teleflex, Wayne, PA, USA). This aims to prevent 
any inflow of blood from the systemic circulation into the CTO segment and thus the SIS 
with an ultimate goal of minimizing any distal hematoma (Figure 4). The preservation of 
the landing zone aids the efficacy of re-entry, whilst the use of the Trapliner (if available) will 
facilitate efficient device exchanges. Many operators will then site a micro-catheter in the 
CTO segment and advance a knuckled guidewire over a proportion of the lesion. Whilst more 
disruptive than using a CrossBoss, this will usually lead to rapid progress, avoidance of side 
branches and potentially lead to safer crossing of tortuous or ambiguous segments. When 
the main vessel architecture is reached, the CrossBoss is used by many operators at this stage 
to create a smaller, less disruptive and more controlled dissection plane for the distal 2–3cm 
of the lesion at the landing zone. Once again, this step will help to minimize hematoma 
formation and enhance the efficacy of the re-entry step.
After the Stingray has been successfully delivered we would recommend routinely attaching 
a Luer lock syringe to the central port proximally and aspirate with a large syringe on vacuum 
for a period of a few minutes. After inflating the Stingray balloon and finding the correct 
orientation for re-entry on X-ray, the puncture is performed (Figure 6). This represents 
another area of evolving practice. The Stingray wire is a dedicated device that has a small 
micro-barb at the distal tip (Figure 1). The concept behind this design was that this would 
‘catch’ the intimal tissue and facilitate re-entry. Whilst this is often true where there is a 
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Figure 2. Example of ADR as a bailout for sub-intimal wire passage in contemporary practice. (A) There is a 25–
30mm CTO of the mid RCA. (B) A Pilot 200 advances into the CTO and beyond the distal cap but is in a subintimal 
position. (C) Blunt dissection is not required, rather the micro-catheter is advanced to the landing zone to 
facilitate delivery of the Stingray. (D) The Stingray is exchanged into the vessel, inflated and orientated with the 
target vessel on the left of the balloon. (E) Final result after successful re-entry and vessel reconstruction. 
ADR = antegrade dissection and re-entry; CTO = coronary chronic total occlusion; RCA = right coronary artery;  
RV = right ventricular; SIS = sub-intimal space.
closely approximated balloon to a healthy distal landing zone, this aspect of wire design can 
be unhelpful where there is a large burden of atheroma (often calcific) between the balloon 
and the lumen (Figure 7). Many operators now prefer a high penetration force, tapered tip 
wire to attempt re-entry (e.g. Confienza Pro 12 or Astato 8/20; Asahi Intecc, Seto, Japan or 
Hornet 14; Boston Scientific) under these circumstances.
Once re-entry has been successfully achieved, the same principles apply as initially described 
with the ADR technique. A micro-catheter should be used to exchange the stiff re-entry wire 
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Figure 3. Ideal anatomy for a primary ADR procedure using the CrossBoss and Stingray system 
ADR = antegrade dissection and re-entry; CTO = coronary chronic total occlusion; PDA = posterior descending 
artery; PLV = posterolateral vessel.
Compression of lumen
Intimal plaque
Sub-intimal
hematoma
Figure 4. Development of intramural hematoma and compression of the distal landing zone if the sub-intimal 
space is exposed to systemic blood flow.
for a safer workhorse wire. This minimizes the risk of distal wire exit, distal vessel dissection 
and will allow a safer completion of the procedure. With a guide catheter extension already in 
situ, stent deployment and optimization is typically efficient.
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Figure 5. Treatment of the lesion depicted in Figure 3. (A) A resistant proximal cap is crossed with a combination 
of a Confienza Pro 12 (Asahi Intecc) and Turnpike Gold (Teleflex). (B) The stiff wire is removed and swapped out 
for a low penetration force, polymer-jacketed knuckle wire. (C) The proximal cap is dilated with a 2.5mm balloon 
to facilitate the introduction of a Trapliner (Teleflex). (D) A CrossBoss is then used to complete a controlled 
dissection to the landing zone. (E) The Trapliner facilitates efficient delivery of a Stingray balloon to allow 
controlled re-entry to occur. (F) Final result after stent deployment and optimization.
X-ray beam orientated “en face”, relative to the Stingray balloon
X-ray beam orientated perpendicular relative to the Stingray balloon
Both wings visualised
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Figure 6. Correct angiographic orientation of the Stingray balloon.
OUTCOMES AFTER CORONARY CHRONIC TOTAL 
OCCLUSION PERCUTANEOUS CORONARY 
INTERVENTION WITH DIFFERENT STRATEGIES
ADR represents an umbrella term that covers a spectrum of different approaches. The 
procedural efficacy of contemporary ADR varies with the complexity of the lesion and the 
extent of supplementary maneuvers that are required during the case.14) In the Recharge 
registry,15) the use of ADR as a technique either primarily or as a bailout during switching of 
strategies was an important facet of achieving 89% success overall. Closer examination of 
the ADR sub-group14) demonstrated 81% success with CrossBoss and Stingray as a primary 
technique. If supplementary techniques such as wire based redirection or knuckling were 
used, this reduced to 74% reflecting increased lesion and technical complexity. When used as 
a bailout for failed AW or retrograde based procedures the success was 61%. The CrossBoss 
alone crossed true-to-true in 7% of the successful ADR cases. Finally, wire-based re-entry 
also occurred in a small percentage (10%) of successful ADR cases (either bailout LAST or 
inadvertent mini-STAR close to the distal cap). Failure modes of ADR are well described 
and this procedure is most commonly limited by the formation of a distal hematoma at the 
landing zone16) or failure of equipment to reach the landing zone.14)
It is important that operators recognize that there are risks inherent to any CTO procedure 
irrespective of approach. This is particularly pertinent when lesions are complex and 
potentially amenable to 2 or more strategies. Large registry data show that retrograde 
approaches are associated with increased jeopardy compared to AW or ADR approaches. The 
need for retrograde access increases the risk of perforation and peri-procedural myocardial 
infarction.17) Therefore, it is important that cardiologists recognize procedural jeopardy and 
employ a strategy and or technologies under circumstances that make the procedure as safe as 
possible. For example, using ADR as a strategy may confer much less jeopardy than trying to 
cross small caliber, high-frequency and extremely tortuous epicardial collaterals retrogradely.
As noted, there have been poorer clinical outcomes described with historical ADR 
approaches. However, in centers where all of these strategies were applied, more 
contemporary ADR (and RDR) procedures are associated with vastly superior clinical 
results compared to the older methods of ADR.18) This has been confirmed in large clinical 
registries, where outcomes with modern targeted ADR in particular, appear equivalent to 
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Increasing re-entry difficulty
Increasing distal vessel disease burden and calcification
Figure 7. Examples of different disease burdens at the landing zone. The most rightward example is often 
amenable to re-entry with the Stingray wire, whereas many experienced operators are now using high penetration 
force wires for the scenario on the left.
wire based approaches for 1-year major adverse cardiovascular events.19-21) RDR approaches 
have been associated with a small excess of target vessel revascularization (TVR). However, 
this particular approach is typically reserved for the most complex cases, where there are 
high Japanese CTO scores, high rates of post-coronary artery bypass grafting cases and stent 
lengths are very long.21) The finding of increased restenosis driving more TVR under these 
circumstances is not unsurprising.
CONCLUSION
There is no panacea in CTO PCI, with no single strategy, technology or approach offering 
a solution to the broad spectrum of lesions. ADR represents an important facet of both the 
hybrid and Asia-Pacific algorithms and in some patients may represent a safer approach to 
a lesion. The ability to utilize ADR based approaches amongst the other CTO PCI strategies 
enhances the overall success of the procedure. Finally, when successful, ADR procedures 
are associated with good clinical outcomes for patients that are comparable to wire based 
approaches in the medium term.
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